Delivery Order SPE2DB24D8002-SPE2DB24FJMNR
Award Date
7/16/24
Potential Completion Date
7/17/24
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBQHW, was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of VYVANSE 30 MG CAPSULE 100S. The contract has a ceiling value of $1,013.63 and a performance period through January 29, 2024. This award is not associated with a set-aside program. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified...
This federal contract award, identified as SPE2DX15D8002|SPE2DX23F2XH9, was granted to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The $1,011.24 firm fixed-price delivery order is for the provision of 4560939520 VYVANSE 40 MG CAPSULE 100S, a prescription medication. This contract is not set aside and is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA,...
This federal contract award, identified as SPE2DX15D8003|SPE2DX24F7D8Q, was issued by the Defense Logistics Agency (DLA) for the procurement of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The $2,287.07 firm fixed-price delivery order was awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, on May 20, 2024, with a completion date of May 21, 2024. Dakota Drug, Inc. is a key supplier to the DLA's Troop Support Medical division, holding a $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4562920866 VYVANSE 20 MG CAPSULE 100S. The contract award ID is SPE2DX15D8002|SPE2DX24F2TX1, with a ceiling value of $1,380.43. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is November 29, 2023. This award is not associated with a set-aside program. Dakota Drug, Inc. holds a...
This federal contract award, with ID SPE2DB24D8003|SPE2DB25FJTKA, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,461.18 firm fixed-price delivery order is for the supply of Vyvanse 30 mg capsules. The award is not set-aside and is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC, which is part of the DLA Troop Support...
This federal contract award, identified as SPE2DB24D8001|SPE2DB24FKYZR, was issued by the Defense Logistics Agency (DLA) to prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $1,461.18, is a delivery order for the supply of 4565667427 - VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. The contract has a firm fixed-price pricing structure and an ultimate completion date of September...
This federal contract award, identified as SPE2DB24D8003|SPE2DB25FJTSL, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc. The contract is for the delivery of VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product, with a total ceiling value of $1,899.17 and a period of performance extending through January 29, 2025. The contract is not set aside and is a Firm Fixed Price Delivery Order. Dakota Drug, Inc. is a self-certified small disadvantaged business...
The Defense Logistics Agency (DLA) awarded a $1,184.36 firm fixed-price delivery order contract to Dakota Drug, Inc., a small disadvantaged business. The contract is for the delivery of VYVANSE 30 MG CAPSULE 100S, a prescription medication. This delivery order falls under Dakota Drug, Inc.'s $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical...
This federal contract award, valued at $1,461.18, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 100 units of the medication VYVANSE 30 MG CAPSULE. The contract has a firm fixed price pricing type and an ultimate completion date of August 15, 2024. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This contract...
This federal contract award, identified as SPE2DB24D8002 and SPE2DB25FJNKY, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 4,567,763,910 units of the prescription medication VYVANSE 30 MG CAPSULE 100S. The contract has a firm fixed price of $2,577.76 and a period of performance through April 2, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota...